-
Fmoc-3-(2-Naphthyl)-L-alanine 112883-43-9
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Letoto la amino acid |Fmoc-3-(2-Naphthyl)-L-alanine |CAS: 112883-43-9 |C28H23NO4
-
Fmoc-Trp(Boc)-OH 143824-78-6
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Fmoc-Trp(Boc)-OH |CAS: 143824-78-6 |C31H30N2O6
-
Fmoc-L-Leucine 35661-60-0
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Letoto la amino acid |Fmoc-L-Leucine |CAS: 35661-60-0 |C21H23NO4
-
Fmoc-D-leucine 114360-54-2
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Letoto la amino acid |Fmoc-D-leucine |CAS: 114360-54-2 |C21H23NO4
-
N6 - [(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine 1202003-49-3
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-lysine |CAS: 1202003-49-3 |C27H34N2O6
-
O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine 1013883-02-7
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |O-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine |CAS: 1013883-02-7 |C31H34N2O7
-
Hippuric acid 495-69-2
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Asiti ea Hippuric |CAS: 495-69-2 |C9H9NO3
-
Valsartan 137862-53-4
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tsa Lik'hemik'hale |Lik'hemik'hale tse tala |Indasteri ea meriana lipakeng |Methapo ea pelo |Phekolo ea khatello ea mali |Valsartan Intermediates |Valsartan |CAS: 137862-53-4 |C24H29N5O3
-
L-Valine methyl ester hydrochloride 6306-52-1
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tsa Lik'hemik'hale |Lik'hemik'hale tse tala |Indasteri ea meriana lipakeng |Methapo ea pelo |Valsartan Intermediates |L-Valine methyl ester hydrochloride |CAS: 6306-52-1 |C6H13NO2.HCl
-
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride 482577-59-3
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tsa Lik'hemik'hale |Lik'hemik'hale tse tala |Indasteri ea meriana lipakeng |Methapo ea pelo |Phekolo ea khatello ea mali |Valsartan Intermediates |N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride |CAS: 482577-59-3 |C20H22N2O2.HCl
-
Valsartan methyl ester 137863-17-3
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tsa Lik'hemik'hale |Lik'hemik'hale tse tala |Indasteri ea meriana lipakeng |Methapo ea pelo |Phekolo ea khatello ea mali |Valsartan Intermediates |N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine methyl ester |CAS: 137863-17-3 |C25H31N5O3
-
(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethanol 126534-31-4
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Li-Reagents tsa Pharmaceutical Intermediates |Mafu a tšoaetsanoang |Dermatologic |Luliconazole Intermediates |(S)-2,4-Dichloro-alpha-(chloromethyl)-benzenemethano |CAS: 126534-31-4 |C8H7Cl3O